New Global Study Puts Focus on Patients with Rare ROS1-Positive Cancer

New Global Study Puts Focus on Patients with Rare ROS1-Positive Cancer
A new global study has been launched to help gain a deeper understanding of ROS1 gene fusions, a rare cause of some types of cancers, including ovarian. The initiative is a joint effort by the Addario Lung Cancer Medical Institute (ALCMI), along with Champions Oncology and the ROS1ders, a group of patients and caregivers dealing with ROS1-positive

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *